The cluster of senior insider sales (CCO, Director, Legal Officer) at similar prices without a clear 10b5-1 pattern is a modest bearish signal. Monitor for upcoming earnings or pipeline updates that may have prompted these sales. The CEO's non-cash gift is neutral. Given the small absolute size relative to market cap, this is a watch item, not a trigger for immediate action.
Price Chart
Executive Summary
A cluster of three Jazz Pharmaceuticals insiders sold $3.32M in stock over a one-week window, including the EVP & Chief Commercial Officer ($1.63M) and a Director ($1.41M). The CEO made a non-cash gift of 600 shares. While the total sales represent only ~0.02% of market cap, the cluster includes multiple senior executives selling at similar prices, which warrants attention. No 10b5-1 pattern is evident, and the sales are not routine in size or timing.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $3.32M in JAZZ stock over 7 days (May 28 – June 3, 2026).
- EVP & Chief Commercial Officer Pearce Samantha sold $1.63M (6.9K shares at $235.41).
- Director Cozadd Bruce C sold $1.41M (6.0K shares at $235.12).
- EVP & Chief Legal Officer Patil Neena M sold $282K (1.2K shares at $236.97).
- CEO Gala Renee D made a non-cash gift of 600 shares ($0 value).
- Total sales represent ~0.02% of JAZZ's $15.1B market cap.
- No 10b5-1 plan or regular pattern is disclosed; sales are not clearly routine.
Financial Impact
Total insider sales of $3.32M, or ~0.02% of market cap. While small relative to company size, the cluster of multiple senior executives selling at similar prices is notable.
Risk Factors
- Insider sales may signal management's view that the stock is fairly valued or that near-term catalysts are limited.
- No 10b5-1 plan disclosed increases the likelihood these were discretionary sales.
- The cluster includes the Chief Commercial Officer, whose sale could relate to commercial performance concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-JAZZ-1780692166536 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers